Appeal No. 1999-0400
Application No. 08/316,938
IV. The 35 U.S.C. § 103(a) rejection of claim 4 as being
unpatentable over Edwards in view of Szczesny, Edmonds, Bremer,
Gibson, Moriya and Watson
We shall sustain the standing 35 U.S.C. § 103(a) rejection
of claim 4 as being unpatentable over Edwards in view of
Szczesny, Edmonds, Bremer, Gibson, Moriya and Watson since this
claim stands or falls with claim 1.
V. The 35 U.S.C. § 103(a) rejection of claims 1, 7, 8, 12, 14/1
and 31/1 as being unpatentable over Sipos in view of Szczesny,
Edmonds and Bremer
Sipos discloses a process for preparing a buffered bile
acid (UDCA) composition for ingestion by mammals to treat a
variety of medical ailments. The process includes the steps of
(1) micropulverizing the UDCA in the presence of a suitable
buffer salt to obtain an ultrafine particle blend of buffered-
UDCA, (2) wetting the blend with a suitable liquid to cause it
to stick together, (3) granulating or extruding the blend
through a 10 to 18 mesh S/S screen using an
oscillating/reciprocating granulator or a twin-screw extruder
at a medium-to-high speed, (4) classifying the granulated
particles in a uni-sizer vessel that rotates at 15 to 45 rpm
13
Page: Previous 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next
Last modified: November 3, 2007